US FDA Budget Boost Would Increase Domestic Drug Manufacturing By Better Regulating New Technologies
Executive Summary
FDA’s fiscal year 2020 budget request calls for spending on figuring out how to regulate new drug manufacturing technologies under the rubric of increasing US domestic manufacturing.
You may also be interested in...
Biden Vaccination Plan Would Grow Domestic Manufacturing Base
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Individualized Gene Therapy: US FDA Considering Device-Like Manufacturing Approval Process
CBER Director Peter Marks said the agency could streamline development by allowing sponsors to depend on an already-approved manufacturing platform and reviewing any modifications that are proposed.
US FDA Gets Another Appropriations Increase In FY 2020 House Bill
Overall percentage increase is not as high as the FY 2019 spending bill, but stakeholders are happy with the proposed boost in budget authority.